Store brand Vioxx alternatives
This article was originally published in The Tan Sheet
Executive Summary
Leiner Health Products is capitalizing on Merck's recent withdrawal of Vioxx (rofecoxib) through in-store signage for its store-brand pain relievers. Leiner is working with retailers to place shelf-talkers with phrases such as "proven safe and effective to treat minor arthritis pain" next to products like naproxen sodium. The effort follows a recent spate of ads touting OTC use over COX-2 inhibitors (1"The Tan Sheet" Oct. 11, 2004, p. 3)...
You may also be interested in...
Wyeth, McNeil Strike Swiftly With Ads After Vioxx Recall
Wyeth Consumer Health and McNeil are capitalizing on concerns generated by Merck's recall of its prescription pain reliever Vioxx with ads for Advil (ibuprofen) and Tylenol (acetaminophen)
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.